Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
about
SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer.A personalized committee classification approach to improving prediction of breast cancer metastasis.Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients.Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1.Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis.Comparative secretomic and N-glycoproteomic profiling in human MCF-7 breast cancer and HMEpC normal epithelial cell lines using a gel-based strategy.Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysisWNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer.Shortening of 3'UTRs correlates with poor prognosis in breast and lung cancer.Revealing Glycoproteins in the Secretome of MCF-7 Human Breast Cancer Cells.Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.The metastasis suppressor, N-myc downregulated gene 1 (NDRG1), is a prognostic biomarker for human colorectal cancer.SPARC expression and prognostic value in non-small cell lung cancer.Maitake Pro4X has anti-cancer activity and prevents oncogenesis in BALBc mice.Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model.Potential options for managing LOX+ ER- breast cancer patientsFirst line treatment of advanced non-small-cell lung cancer - specific focus on albumin bound paclitaxel.SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer.Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer.Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors.Inhibition of N-Myc down regulated gene 1 in in vitro cultured human glioblastoma cells.Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.NDRG1 Controls Gastric Cancer Migration and Invasion through Regulating MMP-9.NDRG1 expression is related to the progression and prognosis of gastric cancer patients through modulating proliferation, invasion and cell cycle of gastric cancer cells.Association of NDRG1 gene promoter methylation with reduced NDRG1 expression in gastric cancer cells and tissue specimens.N-myc downstream-regulated gene 1/Cap43 may function as tumor suppressor in endometrial cancer.Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas.Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer.SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer.Secreted protein acidic and rich in cysteine (SPARC) induces cell migration and epithelial mesenchymal transition through WNK1/snail in non-small cell lung cancer.4th international conference on tumor progression and therapeutic resistance: meeting report.Osteonectin expression in surrounding stroma of craniopharyngiomas: association with recurrence rate and brain infiltration.The relationship between stromal cell derived SPARC in human gastric cancer tissue and its clinicopathologic significance.NDRG1/Cap43 overexpression in tumor tissues and serum from lung cancer patients.High secreted protein acidic and rich in cysteine expression in peritumoral fibroblasts predicts better prognosis in patients with resectable gastric cancer.A meta-analysis of biomarkers for the prognosis of triple-negative breast cancer patients.
P2860
Q31083068-088F4E82-C87C-4D50-9295-FC71E0BC4C30Q33807643-53F6E1B4-A640-43A9-81F2-46AB41A159DFQ33917567-892C82E6-FA13-41D1-AEA2-01A31E02B538Q34075151-5DB6A1E1-7935-4FDF-A640-225ABC2F3C69Q34439076-756AB5A0-7F31-4825-9436-69B51A83BC6CQ34645702-2FB392EF-AC9F-4565-A376-82F3820A46C2Q34701521-004BEE6C-9132-47D7-95EF-4253EC5C5AD6Q35138841-32AE7C19-F1D7-404C-9E10-A67DFA7991A6Q35745093-01A431A3-BD32-4A69-BE7D-EBE2E333DEFEQ35807042-1EA3121D-B383-40BD-AEF5-432E2FEFE73BQ35840714-31F21414-5252-4F6A-99AB-05BE6B0E4578Q36997381-BE025071-E62A-4C25-97DD-C8062D64C76EQ37183762-23AB0A6C-9497-4F72-85BA-FE9874841150Q37321080-05C11D3B-4E4E-42BE-AC83-392CF78D9C69Q37327668-614E1C33-8046-4D4E-A9D2-7612FAA9ACE6Q37362796-0F60E9CC-A281-4561-B6F8-FAB93F7AA907Q37419857-3707FFD9-FAF9-4FA1-929C-921AC1F146AEQ37718256-CF1F04A2-60A6-49C5-93D2-737AA40160ABQ37977498-78B0F3A6-213D-48CE-ADA4-B7539058F1FAQ38106675-40A36BD7-4078-4E3B-83C5-AEBD85A8A339Q38323649-74992331-FEF5-453F-8719-E7624A4C597FQ38757854-3C8838D2-5F1C-4F5A-880A-B11AB4944D2FQ38772665-50F97C7A-55B2-4ECD-A0FC-85D246B227DCQ38978918-D066D098-1B46-4B67-AB05-F758FE917DEDQ39253213-56A313A2-EF0B-4E53-A9E7-99F51FC8EE31Q39335108-4F1A5613-3F83-4756-9AF7-D0740A048A27Q40058161-15F435CE-1FC0-487F-A7CF-71E25C95438AQ41183233-930EB46F-35EC-4728-97CE-0F31912C942EQ41642309-FEC570E9-49A6-4BD4-BCD1-8D7AE2CFC238Q42362739-8830F876-3A84-4EDA-BF6B-B978CBF83F7FQ43200018-AABAEA08-7620-406C-B6EB-C18D595117B4Q44641509-8ABCE6DF-D7C5-4C77-9887-2D365C3165D7Q47165057-A509DD03-55CF-43CE-A353-FCA3322C0960Q47590619-EFDC3A61-D25B-4D33-9BC5-E692004BA837Q49325052-C699FA23-A19D-41BE-9218-3C9A5773AD8CQ51684386-D3BEBBE9-C127-4493-B285-C334886FB773
P2860
Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
@en
Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
@nl
type
label
Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
@en
Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
@nl
prefLabel
Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
@en
Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
@nl
P2093
P2860
P1476
Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients
@en
P2093
José Humberto T G Fregnani
Mário Mourão Netto
Regina Barbosa Rierger
Renê Gerhard
Suely Nonogaki
P2860
P2888
P356
10.1007/S10549-010-0867-2
P407
P577
2010-04-06T00:00:00Z